Health and Healthcare
5864 Articles
A new Jefferies research report highlights their top growth picks for this week, and the list is dominated by top…
Raptor Pharmaceuticals saw its shares sink on Monday after it announced its first commercial sale of Quinsair in Germany and…
Insys Therapeutics watched its stock slide early Monday morning following the release of less-than-favorable revenue estimates.
Over the past week, Valeant Pharmaceuticals and a few other biotech companies made impressive runs.
Depomed saw its stock surge early Friday morning following news of an open letter from activist firm Starboard Value.
If the momentum in biotech can continue, then companies with catalysts within the next 12 to 18 months could get…
Ionis Pharmaceuticals made waves in the market on Thursday following a business update on its IONIS-TTR program.
Aeglea BioTherapeutics entered the market quietly on Thursday morning, with pricing below the expected range of $16 to $18 per…
It is no secret that we have an aging population, and it requires more and more hospital treatment, whether it…
Janney Montgomery Scott reiterated its Buy rating and $15 fair value estimate on Sangamo Biosciences as it brings multiple programs…
Despite a modest erosion to fundamentals and sector headwinds, Jefferies does not anticipate any dramatic earnings misses, which could help…
This week's top U.S. growth calls from the analysts at Jefferies focus on companies that have some outstanding upside potential,…
At the end of March, a district court granted the request from Depomed and lifted the stay of its patent…
Not only does Aldeyra Therapeutics have a good cash position, but it also it has a strong pipeline as well.…
Over the past week, Opko Health, Acadia Pharmaceuticals and a few other biotech companies made impressive runs.
Our top personal finance-related articles today. Your wallet will thank you later.